N. ÜSKENT Et Al. , "1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy," ESMO , 2019
ÜSKENT, N. Et Al. 2019. 1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy. ESMO .
ÜSKENT, N., ÖZKAN, M., DOĞAN, E., YAZAR, A., teomete, m., & BERK, V., (2019). 1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy . ESMO
ÜSKENT, NECDET Et Al. "1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy," ESMO, 2019
ÜSKENT, NECDET Et Al. "1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy." ESMO , 2019
ÜSKENT, N. Et Al. (2019) . "1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy." ESMO .
@conferencepaper{conferencepaper, author={NECDET ÜSKENT Et Al. }, title={1266PPrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy}, congress name={ESMO}, city={}, country={}, year={2019}}